A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
Enrolling by invitation · NCT06275620 · Registry updated 2024-10-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN) | Eye Diseases, Hereditary, eye disorder, retinal degeneration, retinal disorder | Enrolling by invitation | Phase 2 | 2024-10-30 | NCT06275620 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beacon Therapeutics | 5 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bascom Palmer Eye Institute | Miami | United States | 17 |
| Boston Children's Hospital | Boston | United States | 343 |
| Casey Eye Institute | Portland | United States | 9 |
| Cincinnati Eye Institute | Cincinnati | United States | 22 |
| Cleveland Clinic | Cleveland | United States | 558 |
| Retina Foundation of the Southwest | Dallas | United States | 38 |
| University of Florida | Jacksonville | United States | 15 |